Loading company…
ShiraTronics, Inc., based in Minneapolis, develops implanted neuromodulation therapy for chronic migraine.
Founded by Lynn Elliott and Mudit Jain, with Lynn Elliott as CEO, ShiraTronics, Inc. is headquartered in Minneapolis, US, and operates in the United States and Australia. Its migraine-specific device is surgically implanted under the skin to deliver continuous stimulation to targeted nerves, aiming to relieve and prevent chronic migraine symptoms. In September 2024 the company raised USD 37.396 mn in Series B funding led by Norwest Venture Partners, part of USD 66 mn total Series B, to support the FDA-approved RELIEV-CM2 clinical study and commercial launch.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in